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Objective: To evaluate the impact of endograft type on the inﬂammatory response after elective endovascular repair of
abdominal aortic aneurysms.
Methods: From January 2011 to November 2011, we included 100 consecutive patients who underwent elective
abdominal aortic aneurysm endovascular repair. Thirteen patients were excluded from the analysis: four with cancer, three
with autoimmune disease, two because of recent infection, two who were receiving long-term anti-inﬂammatory medi-
cation, and two because of recent surgery. Temperature, white blood cell count, platelet count, and serum concentrations
of cytokines (interleukin [IL]-6, IL-8, and IL-10) were measured preoperatively, 24 hours postoperatively, and 48 hours
postoperatively. The study sample was divided into four groups with respect to the type of endograft used: group A, n[
28 (Anaconda; Sulzer Vascutek, Bad Soden, Germany); group B, n [ 26 (Zenith; Cook Inc, Bloomington, Ind); group
C, n[ 23 (Excluder; W. L. Gore and Assoc, Flagstaff, Ariz); and group D, n[ 10 (Endurant; Medtronic, Minneapolis,
Minn). Endograft conﬁgurations included bifurcated grafts only.
Results: Epidemiologic characteristics, atherosclerotic risk factors, type of anesthesia, mean blood loss during surgery, and
baseline serum levels of cytokines did not differ among the four groups. Mean elevated temperature was more pronounced
postoperatively in group A. Serum levels of IL-6 and IL-10 were signiﬁcantly higher 24 hours and 48 hours post-
operatively compared with preoperative levels in all groups. Patients in group C showed the smallest increase in levels of
serum IL-6 and IL-10 at 24 hours and 48 hours postoperatively. Mean difference in cytokine levels after aneurysm
exclusion was greater for group A vs group C (P < .01) compared with group A vs B (P < .05). No differences in the
mortality and morbidity rates were observed among the four groups.
Conclusions: Endograft type appears to inﬂuence the inﬂammatory response after endovascular aortic repair. The post-
implantation syndrome was apparent during the ﬁrst 24 hours and decreased afterward. Anaconda and Zenith endografts
induced a more intense inﬂammatory response. A “milder” inﬂammatory activation was observed in patients with an
Excluder endograft. The postimplantation syndrome was not associated with perioperative adverse clinical events showing
a benign course. The possible long-term sequelae of postimplantation syndrome require further investigation. (J Vasc
Surg 2013;57:668-77.)The endovascular treatment of abdominal aortic aneu-
rysms (AAAs) frequently induces a systemic inﬂammatory
response known as postimplantation syndrome (PIS). This
syndrome is usually transient during the early postoperative
phase and is characterized by fever, leukocytosis, coagula-
tion disturbances, and an increase of inﬂammatory markers
in patients’ blood.1-5 Apart from the discomfort, the impactthe Department of Vascular Surgerya and Department of Cytopatho-
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patients is a concern because it may lead to prolonged hospi-
talization and a more complicated postoperative recovery.
Reportedly, systemic inﬂammatory response may result in
several complications, such as cardiac events and renal and
pulmonary dysfunction, sometimes leading to acute respira-
tory distress syndrome or multiple organ failure.6
Possible causes for this inﬂammatory response are endo-
vascular instrumentation of the mural thrombus, endovas-
cular instrumentation of the endothelium, activation of
biologic mediators secondary to the identiﬁcation of the
endograft as an extrinsic prosthetic material, and thrombosis
of the aneurysm sac after the aneurysm exclusion.1,2,4,6,7
Textured material is exposed to the bloodstream, and its
surface activates inﬂammatory mediators.1,6 Some authors
suggest that manipulation of the aneurysm during endovas-
cular aortic repair (EVAR) may cause white blood cell
(WBC) activation and the release of various cytokines,
whereas others suggest that injury to the vascular endothe-
lium may cause prompt activation of protein C, with subse-
quent coagulopathy and loss of cytoprotectivity.8-10
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impact of endograft type on the inﬂammatory response
after elective EVAR of AAAs.
METHODS
Study sample. From January 2011 to November
2011, 100 consecutive patients who underwent elective
endovascular repair of asymptomatic infrarenal AAAs in
our department were prospectively enrolled in the study
protocol. All patients underwent preoperative computed
tomography angiography and laboratory investigation,
including complete blood count and biochemical investiga-
tions. Thirteen patients were excluded from the study.
Exclusion criteria were as follows:
d Any sign of recent (<15 days) infection (including body
temperature >37.2C and WBC count >11,000/mL),
ﬁndings of pulmonary infection, skin infection, and
recent (<15 days) antibiotic therapy (n ¼ 2 patients)
d Surgical operation or trauma during the last 2 months
(n ¼ 2 patients)
d A history of autoimmune or systemic inﬂammatory
disorder for which the patient was receiving treatment
with anti-inﬂammatory, immunodepressant agents
(n ¼ 5 patients)
d A history of malignant disease (n ¼ 4 patients)
Informed consent was obtained from all study partici-
pants, and the study protocol was approved by the institu-
tional review board.
Endovascular technique. The type of endograft in
each patient was decided after meticulous consideration
of the anatomic characteristics of the aneurysm with use
of three-dimensional reconstruction software and subse-
quent discussion by the team of vascular surgeons. The
procedures were performed in an operating room equip-
ped with a portable C-arm with angiographic and road-
mapping capabilities. Patients were administered general
or epidural anesthesia based on their comorbidities. Per-
ioperative antibiotic prophylaxis with intravenous van-
comycin (1 g) and piperacillin plus tazobactam (4.5 g)
was administered 1 hour before and 12 hours after the
operation. The patient was placed in the supine position,
both groins and the entire abdomen were prepared and
draped, and simultaneous bilateral access to the common
femoral arteries (two vascular teams) was obtained via
femoral artery preparation cut-down. Systemic heparin-
ization of the patient was achieved with 5000 IU of
heparin.
Variables of interest. Demographics (age, gender),
body mass index ( kg/m2), risk factors (eg, hypertension,
dyslipidemia, diabetes mellitus, cardiac arterial disease,
chronic obstructive pulmonary disease, smoking, use of
statins), aneurysm diameter (in centimeters), contrast
media volume, operative time (minutes), hospitalization
(days), type of anesthesia (general or epidural), periproce-
dural blood loss (in milliliters), 30-day mortality and
morbidity, duration of surgery (seconds), and presence ofendoleak (computed tomography scan performed at ﬁrst
month of follow-up) were recorded for each patient. The
amount of mural thrombus detected on preoperative
computed tomography angiography was scored as follows:
0%, no visible thrombus; <25% of the cross-sectional area;
25% to 50% of the cross-sectional area; >50% of the cross-
sectional area.11 Temperature was recorded every 4 hours
the day before surgery and during the ﬁrst and second
postoperative day. The highest values preoperatively and
during postoperative days 1 and 2 were considered for the
analysis.
The study patients were divided into four groups with
regard to the type of endograft used: group A, n ¼ 28
(Anaconda; Sulzer Vascutek, Bad Soden, Germany); group
B, n ¼ 26 (Zenith; CookInc, Bloomington, Ind); group C,
n ¼ 23 (Excluder; W. L. Gore and Assoc, Flagstaff, Ariz);
and group D, n ¼ 10 (Endurant; Medtronic, Minneapolis,
Minn). Endograft conﬁgurations included bifurcated grafts
only.
Blood samples and laboratory evaluation. All partic-
ipants were examined during morning hours after a 20-
minute rest period 1 day before the operation and 24
hours and 48 hours after the operative procedure. Blood
samples were centrifuged at 2500 rpm for 10 minutes. The
supernatant serum was withdrawn and stored at 80C
until processed. A multiplex bead-based assay was used to
determine the concentration of interleukin (IL)-6, IL-8,
and IL-10 in the serum.
Serum concentrations of IL-6, IL-8, and IL-10 were
determined with the Milliplex High Sensitivity Cytokine/
Chemokine kit (Millipore Corp, Billerica, Mass) according
to the manufacturer’s instructions. The ﬁlter plate was pre-
washed with 200 mL of wash buffer on a plate shaker for 10
minutes at room temperature. The wash buffer was
removed by vacuum, and 25 mL of the beads were added
to each well. Liquid was removed by vacuum, and 50 mL
of standards, controls, assay buffer, matrix solution, and
serum sample was added to the appropriate wells. The plate
was incubated with agitation overnight (16-18 hours) at
4C. After several washes, 50 mL of detection antibodies
were added and incubated for 1 hour at room temperature
followed by the addition of 50 mL of streptavidin-
phycoerythrin and incubation for 30 minutes. Finally,
100 mL of sheath ﬂuid was added to each well, and the
beads were resuspended for 5 minutes on a plate shaker.
The analysis was performed on the Luminex 200 platform
(Luminex Corp, Austin, Tex).
Medications. Antiplatelet medication was discontinued
and switched to low-molecular-weight heparin in patients
undergoing epidural anesthesia. Almost one-third of patients
were receiving statins on admission. In many patients,
the diagnosis of the aneurysm was an incidental ﬁnding
during a physical or imaging examination for a different
pathology. All of these patients were started on statin therapy
preoperatively and prescribed long-term medication on
discharge. No postoperative anti-inﬂammatory drugs were
administered to the patients. Patients with a fever (>37.8C)
were given acetaminophen. Acetaminophen has antipyretic
Table I. Baseline characteristics among patients with different endograft type
Group A (n ¼ 28) Group B (n ¼ 26) Group C (n ¼ 23) Group D (n ¼ 10)
PMean (SE) Mean (SE) Mean (SE) Mean (SE)
Age, years 73.11 (0.86) 73.08 (1.06) 70.87 (1.34) 74.17 (1.55) .30
Aneurysm size, cm 5.49 (0.04) 5.59 (0.16) 5.31 (0.06) 5.35 (0.18) .31
% % % % P
- Men 92.6 96.2 95.7 83.3 .49
- CAD 25.9 34.6 39.1 33.3 .79
- Hypertension 40.7 61.5 60.9 66.7 .30
- COPD 18.5 19.2 13.0 33.3 .55
- Dyslipidemia 33.3 15.4 30.4 33.3 .44
- DM 11.1 15.4 8.7 33.3 .24
- Smoking 37.0 38.5 34.8 50.0 .84
Statin on admission 25.9 26.9 26.1 33.3 .97
Antiplatelet 35.7 26.9 39.1 30.0 .92
b-blockers 14.3 19.2 13.0 20.0 .94
Antihypertensive 60.7 57.7 56.5 60.0 .98
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; SE, standard error.
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acetaminophen is not fully understood. It is not a nonste-
roidal anti-inﬂammatory drug (NSAID), and it is believed
to have a weak inhibitory action in prostaglandin formation.
Statistical analysis. Continuous variables were
expressed as mean 6 standard error (SE). Standard statis-
tical procedures (nonparametric c2 distribution with corre-
sponding P values) were used to assess the differences
among categorical variables with regard to endograft
type. Analysis of variance (ANOVA) was used to analyze
the variation of continuous variables of patient and peripro-
cedural characteristics within types of endograft used.
Cytokines and temperature were submitted to a repeated-
measures ANOVA, analyzing the factors of time and time
by type of endograft used interaction. When sphericity
conditions were not reached, the degrees of freedom of the
repeated factors were corrected with the Greenhouse-
Geisser correction factor. Differences of cytokines and
temperature between baseline, 24 hours postoperative, and
48 hours postoperative values (D scores) were calculated for
each patient in three comparison groups (D1 ¼ 24 hours
minus baseline, D2¼ 48 hours minus baseline, and D3¼ 24
hours minus 48 hours) and expressed as mean differences.
Whenever a signiﬁcant time or time by type of endograft
used interaction occurred, comparisons among the groups
were made at each phase using a one-factor ANOVA fol-
lowed by multiple comparisons with the Bonferroni test. To
explore correlation between the amount of mural thrombus
in the AAA before repair and markers of PIS, Spearman
r correlation coefﬁcient was calculated among cytokines
(IL-10, IL-8, IL-6), temperature, WBCs, and platelets and
four categories of AAA sac clot. A P value of .05 was
considered statistically signiﬁcant. Statistical analysis was
conducted using SPSS version 16.0 for Windows (SPSS Inc,
Chicago, Ill).
RESULTS
Baseline patient characteristics. Patient characteris-
tics at baseline are presented in Table I. No statisticallysigniﬁcant differences were observed in demographics,
atherosclerotic risk factors, drug medication, and aneurysm
size among patients treated with different types of endo-
grafts. No differences in perioperative characteristics (blood
loss, contrast media volume, type of anesthesia, duration of
surgery) were observed among the four groups (Table II).
Endografts were successfully implanted in all patients.
There were no open conversions, no deaths, and no major
perioperative complications. There was no postoperative
increase in troponin levels. Minor complications included
local hematomas in femoral incisions in three patients (one
each in group A, group B, and group C), who were treated
conservatively. Mural thrombus classiﬁcation in our sample
was as follows: 0%, 9 cases (10%); 0% to 25%, 31 cases
(36%); 25% to 50%, 9 cases (10%); >50%, 38 cases (44%).
No statistically signiﬁcant association was recorded among
classiﬁcation of mural thrombus and different types of
endografts. At 1-month follow-up, endoleaks were recor-
ded in 12 (13.8%) patients (group A, n ¼ 5 patients; 17.9%;
group B, n ¼ 3 patients; 11.5%; group C, n ¼ 3 patients;
13.0%; group D, 1 patient; 10%) (Table II). No statistically
signiﬁcant differences were recorded for the presence of
endoleak, operative time, and contrast volume adminis-
tered intraoperatively, with regard to the endograft type.
Cytokines, WBCs, platelets (PTL), and tempera-
ture changes. Mean (SE) values of cytokines (IL-10, IL-6,
IL-8), WBCs, PTL, and temperature at baseline, 24 hours
postoperatively, and 48 hours postoperatively are presented
in Table III. Regarding cytokines, repeated-measures
ANOVA showed a signiﬁcant effect of time (IL-10, F ¼
19.81, P < .001; IL-8, F ¼ 12.15, P < .001; IL-6, F ¼
48.87, P < .001), which was also evident with regard to
temperature (F ¼ 218.55, P < .001). Time by type of
endograft interaction was also statistically signiﬁcant (IL-
10, F ¼ 9.01, P < .001; IL-6, F ¼ 8.25, P < .001;
temperature, F ¼ 9.77, P < .001). Post-hoc pairwise
comparisons showed that D1 scores (mean values in 24
hours minus mean baseline values) were positive and
statistically signiﬁcant for all cytokines and temperatures
Table II. Perioperative characteristics (type of anesthesia, blood loss, contrast media volume, and duration of surgery)
Group A (n ¼ 28) Group B (n ¼ 26) Group C (n ¼ 23) Group D (n ¼ 10) P
General anesthesia 50% 46.2% 65.2% 40% .31
Mean (SE) Mean (SE) Mean (SE) Mean (SE)
Blood loss, mL 266.2 (16.21) 258.2 (21.35) 313.91 (60.89) 300 (16.28) .64
Contrast media volume, mL 176.6 (7.84) 194.2 (15.56) 157.39 (8.39) 192.2 (12.21) .12
Duration of surgery, minutes 53.2 (6.25) 59.8 (5.61) 55.1 (5.2) 58.75 (6.6) .42
SE, Standard error.
Table III. Mean (SE) values of cytokines, WBCs, PLTs, and temperature at baseline, 24 hours, and 48 hours
Variable
Mean (SE)
Repeated measures ANOVA Pairwise comparisons
(F, P value)
D1 (24
hourse
baseline)
D2 (48
hourse
baseline)
D3 (24
hourse
48 hours)
Baseline 24 hours 48 hours Time Time  graft P P P
IL-10, pg/mL 7.61 (0.65) 42.95 (6.38) 22.18 (2.19) 19.81 (<.001) 9.01 (<.001) <.001 <.001 .006
IL-8, pg/mL 21.05 (2.20) 50.63 (7.70) 23.58 (1.76) 12.15 (<.001) 1.58 (.19) .001 NS .002
IL-6, pg/mL 4.54 (0.40) 82.24 (9.71) 67.61 (5.21) 48.87 (<.001) 8.25 (<.001) <.001 <.001 NS
Temperature, C 36.87 (0.03) 37.95 (0.05) 37.45 (0.04) 218.55 (<.001) 9.77 (<.001) <.001 <.001 <.001
WBCs,  103/mL 7.11 (0.16) 11.10 (0.25) 11.85 (0.36) 236.77 (<.001) 25.52(<.001) <.001 <.001 NS
PLTs,  103/mL 192.25 (3.32) 161.10 (3.58) 172.93 (3.55) 63.82 (<.001) 1.95 (.10) <.001 <.001 <.001
ANOVA, Analysis of variance; IL, interleukin; NS, not signiﬁcant; PLTs, platelets; SE, standard error; WBCs, white blood cells.
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mean baseline values were also positive and statistically
signiﬁcant for IL-10 (P < .001), IL-6 (P < .001),
and temperature (P < .001). IL-10 (P ¼ .006), IL-8
(P ¼ .002), and temperature (P < .001) were also pre-
sented with positive and signiﬁcant D2 scores (Table III).
Negative and statistically signiﬁcant (P < .001) D1, D2,
and D3 scores were shown for PTL (Table III).
Cytokines, WBCs, PTL, and temperature changes
among patients with different types of endografts.
Table IV presents the mean (SE) values of cytokines
(Fig, a) and temperature at baseline, 24 hours post-
operatively, and 48 hours postoperatively among the
different types of endografts. No baseline differences were
recorded.
With regard to IL-10 (Fig, b), the Anaconda group
showed the highest mean value at 24 hours and differed
signiﬁcantly from the Excluder (P < .001) and Endurant
(P ¼ .04) groups. The Zenith group also showed higher
mean values than the Excluder (P ¼ .01). Comparisons
among the groups of endograft types at 48 hours showed
that mean values in patients treated with Anaconda endo-
grafts were higher compared with Endurant (P < .001)
and Excluder (P < .001) endografts, whereas mean values
in patients treated with Zenith endografts were signiﬁcantly
higher compared with Endurant (P < .001) and Excluder
(P < .001) endografts.
Patients treated with Anaconda endografts showed the
highest IL-6 mean values at 24 hours postoperatively
(Fig, c). Statistically signiﬁcant differences were observedamong patients treated with the Anaconda vs the Excluder
(P < .001), Anaconda vs Endurant (P ¼ .04), and
Zenith vs Excluder (P ¼ .01). Comparisons at 48 hours
showed signiﬁcant differences for Anaconda vs Excluder
(P < .001), Anaconda vs Endurant (P < .001), Zenith vs
Excluder (P < .001), and Zenith vs Endurant (P < .001).
With regard to IL-8, although patients treated with
Anaconda endografts showed the highest mean values at
24 hours and 48 hours postoperatively, no statistical differ-
ences were observed among the patients treated with
different types of endografts (Fig, d). Patients in the
Excluder group showed statistically lower mean values at
24 hours and 48 hours postoperatively.
Mean baseline temperature did not differ among the
different endograft groups (Fig, e). At 24 hours postoper-
atively, patients showed signiﬁcant temperature differences
for the Anaconda vs the Excluder (P < .001), the
Anaconda vs the Endurant (P ¼ .01), the Anaconda vs
the Zenith (P ¼ .03), and the Zenith vs the Excluder
(P ¼ .02). At 48 hours postoperatively, patients treated
with the Anaconda endograft showed statistically higher
mean values compared with the Excluder (P ¼ .03) and
Zenith (P ¼ .02) endografts.
No statistically signiﬁcant baseline differences were
observed with regard to WBCs and PTL among the types
of endografts. Concerning WBCs (Fig, f), higher mean
values were recorded after 24 hours in patients treated
with the Anaconda endograft compared with the Excluder
(P< .001) andZenith (P< .001) endografts and theEndur-
ant endograft compared with the Excluder (P ¼ .001) and
Table IV. Mean (SE) values of cytokines, temperature, WBCs, and PLTs at baseline, 24 hours, and 48 hours among the
different types of endografts
Group A
(n ¼ 28)
Group B
(n ¼ 26)
Group C
(n ¼ 23)
Group D
(n ¼ 10)
Statistically signiﬁcant comparisonsMean SE Mean SE Mean SE Mean SE
IL-10, pg/mL
baseline 8.15 1.14 6.98 1.33 6.07 1.08 10.68 1.85 —
24 hours 85.49 16.65 39.56 7.24 9.46 1.36 18.75 1.61 A > Ex, A > E, Z > Ex
48 hours 27.11 2.73 37.68 5.02 6.15 0.40 8.20 0.32 A > Ex, A > E, Z > E, Z > Ex
IL-6, pg/mL
baseline 3.98 0.63 4.28 0.83 5.45 0.96 4.64 0.46 —
24 hours 127.03 21.67 107.50 17.67 18.39 1.95 49.09 8.37 A > Ex, A > E, Z > Ex
48 hours 96.84 8.49 100.63 6.31 21.21 2.17 19.26 1.10 A > E, A > Ex, Z > E, Z > Ex
IL-8, pg/mL
baseline 20.40 5.97 24.00 3.83 18.81 2.09 20.37 0.19 —
24 hours 71.40 22.31 51.00 8.96 20.27 2.60 61.28 10.47 —
48 hours 31.24 4.24 25.38 2.11 14.21 2.81 20.40 1.57 —
Temperature, C
baseline 36.78 0.02 36.93 0.06 36.96 0.08 36.73 0.03 —
24 hours 38.30 0.11 37.97 0.05 37.61 0.09 37.73 0.07 A > Ex, A > Z, A > E, Z > Ex
48 hours 37.67 0.04 37.35 0.05 37.28 0.08 37.53 0.11 A > Ex, A > Z
WBCs,  103/mL
baseline 7.24 0.29 6.71 0.29 7.51 0.31 6.93 0.43 —
24 hours 12.86 0.37 10.12 0.37 9.54 0.40 12.21 0.55 A > En, A > Z, En > Z, En > Ex
48 hours 15.53 0.43 10.80 0.44 8.85 0.46 11.64 0.64 A > Ex, A > Z, A > En, En > Ex, Z > Ex
PLTs,  103/mL
baseline 204.63 5.86 184.69 5.98 187.96 6.35 189.00 8.80 —
24 hours 164.48 6.48 158.12 6.61 166.74 7.02 149.17 9.73 —
48 hours 179.22 6.35 169.00 6.48 178.00 6.89 157.58 9.53 —
A, Anaconda; E, Endurant; Ex, Excluder; IL, interleukin; PLTs, platelets; SE, standard error; WBCs, white blood cells; Z, Zenith.
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signiﬁcant differences were observed among Anaconda vs
Excluder (P < .001), Anaconda vs Zenith (P < .001),
Anaconda vs Endurant (P < .001), Endurant vs Excluder
(P ¼ .004), and Zenith vs Excluder (P ¼ .02) groups. No
statistically signiﬁcant differences were observed among
the different endograft types concerning platelet values at
24 hours and 48 hours postoperatively (Table IV).
No statistically signiﬁcant correlation was found
between the categories of the amount of clot in the AAA
before repair and any marker of PIS (all P < .05).
DISCUSSION
We detected an increase in WBCs and serum levels of
cytokines postoperatively in every participant. We found a
variation in the inﬂammatory reaction after EVAR between
patients receiving different endografts, as represented in
WBC counts and serum cytokine levels. After matching
sac thrombus, contrast volume, operative time, and sac
thrombosis, the difference in inﬂammatory response
among endografts persisted. The “milder” reaction was
induced by the Excluder stent graft. This ﬁnding may be
the result of many causes. First, the material used to
compose the endograft. Gore Excluder is made with
expanded polytetraﬂuoroethylene, whereas the other three
grafts are fabricated from woven polyester. Textured mate-
rial is exposed to the bloodstream, and its surface activates
leukocytes and platelets and promotes the release ofinﬂammatory mediators such as cytokines and acute phase
proteins. Different types of biomaterials may provoke
varying inﬂammatory responses. Variations in graft material
have been used to explain different early biologic responses
between open and endovascular aneurysm repair.6 In
a previous study by Gerasimidis et al,10 a signiﬁcant differ-
ence for fever and serum concentrations of IL-8 was
recorded between patients receiving a polyester vs an
expanded polytetraﬂuoroethylene stent graft. This study
failed to show a difference in the serum concentrations of
IL-8, acute phase proteins high-sensitivity C-reactive
protein and alpha1-antitrypsin, and complement protein
C3a. However, a limitation of this study was the perioper-
ative administration of anti-inﬂammatory drugs.10
Another difference between the stent grafts is the inser-
tion technique of the delivery system. The Excluder endo-
graft is inserted through an introducer sheath, in contrast
to the three other endografts, which do not use such
a sheath. Although there are no signiﬁcant differences in
introducer system size, we can assume that the insertion
of a sheath, which is softer and more ﬂexible than the entire
stent graft, may cause less injury to the vascular endothe-
lium. In the absence of a stable guide introducer sheath,
repetitive endovascular maneuvers with withdrawn and
inserted endograft components (main body, iliac exten-
sion) may be associated with additional arterial injury.
Injury to the vascular endothelium is responsible for the
activation of the inﬂammatory process.8,9
Fig. Values of cytokines (a), interleukin (IL)-10 (b), IL-6 (c), IL-8 (d), temperature (e), and white blood cells (f)
among patients with different types of endografts. Values of cytokines are expressed in pg/mL, and temperature is
expressed in C.
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to the material used to compose the endograft. Thickness
and porosity may differ between woven polyester endo-
grafts. Also, the presence of a metallic skeleton with
different conﬁguration and the use of different constructive
materials to build sheaths, main body, and iliac limbs prob-
ably have a role and justify variability in inﬂammatory reac-
tion after EVAR.
Our group of patients had no clinical adverse events
related to postimplantation inﬂammatory syndrome. Weobserved that fever was more intense in the group of
patients receiving the Anaconda stent graft, mainly 24
hours postoperatively. Fever in PIS has been attributed to
diverse etiologies, including bacteria translocation, which
can lead to transitory splanchnic ischemia and the release
of IL-6.12 Although several cytokines may induce fever,
IL-6 produced in the brainstem is required for the ﬁnal
steps leading to fever.13 According to our ﬁndings, the
maximum values of body temperature were positively
correlated with the postoperative values of WBCs, IL-6,
Fig. (Continued)
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We recorded a more intense inﬂammatory response after
Anaconda stent graft implantation compared with the
other three endografts. Gabriel et al12 evaluated the inﬂam-
matory reaction after EVAR and showed that there was an
elevation of IL-6 in all patients, which culminated at 24
hours and triggered the development of fever 24 hours
later. Arnaoutoglou et al14 reported a 35% incidence of
PIS after EVAR consisting of continuous pyrexia despite
antibiotic therapy, negative culture results, leukocytosis,
or coagulation disturbances. Patients with PIS showedsigniﬁcantly greater changes of inﬂammation marker levels,
including high-sensitivity C-reactive protein and IL-6,
compared with the non-PIS group. PIS was associated
with longer hospitalization. In this series, PIS was observed
in all patients in whom an Anaconda graft was deployed,
whereas lower incidence of the syndrome was noted in
patients treated with an Excluder stent graft.14 The
maximum diameter of the aneurysm, the duration of the
procedure, the amount of contrast medium used, and the
age of the patient did not correlate with PIS.14 Our results
are consistent with this study. Videm et al15 suggested that
Fig. (Continued)
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 3 Moulakakis et al 675the contrast medium iohexol induces neutrophil degranu-
lation, which is greatly enhanced when combined with
vascular stent graft material contributing to the postim-
plantation syndrome. This study was based on analysis of
whole blood or isolated neutrophils in ﬁve patients under-
going diagnostic angiography, and the dose for maximal
response ranged from 5 to 50 mg I/mL. In our study,
all patients received larger amounts of contrast agent
(eg, iodixanol [Visipaque]). Statistical analysis showed
that there were no signiﬁcant differences between the
four groups, and we can assume that this parameter did
not inﬂuence the reliability of our results.Platelet activation after elective AAA repair occurs as
the aneurysm sac is thrombosed and by direct stimulation
by the graft material.4 It has been suggested that continued
perfusion of a thrombus-ﬁlled aneurysm sac might predis-
pose patients to acute-on-chronic consumptive coagulop-
athy.16,17 Some coagulation disturbances observed in
the early postoperative period after EVAR surgery, charac-
terized sometimes as part of PIS, can be associated with
this procedure. Cases of disseminated intravascular co-
agulopathy after EVAR have been described.18,19 A recent
study showed that a prothrombotic, hypoﬁbrinolytic diath-
esis associated with AAAs may be normalized after EVAR,
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disease that may protect patients against future thrombo-
embolic cardiovascular events.20 The platelet count is an
indirect index of platelet activation and consumption. In
our study, we found a signiﬁcant decrease in platelet count
at 24 hours postoperatively for all patients. There was no
statistical difference between the four groups, indicating
that this reaction does not depend on the graft type.
This study has limitations. The presence of a control
group could give greater insight to the speciﬁcity and
amount of the inﬂammation response triggered by the
endograft, but it would be difﬁcult to deﬁne the ideal
control group. A point of criticism could be how we
decided on the inﬂammatory factors chosen. Many inﬂam-
matory parameters may be responsible for PIS, including
interleukins, acute phase proteins, and endothelial and
coagulation/lysis activity markers. The reason we chose
these particular cytokines is that they are mainly responsible
for the clinical consequences of PIS, are easily measured,
and have been measured in previous studies investigating
this issue.10,14 The choice of anesthetic technique may
inﬂuence the anti-inﬂammatory cytokine response in
patients undergoing abdominal surgery,21 but the impact
in patients undergoing EVAR is unknown. Because there
were no statistical differences in duration of surgery and
type of anesthesia used among the four groups, we can
assume that the type of anesthesia had similar impact in
the four groups.
The necessity and duration of any speciﬁc treatment in
patients who developed an inﬂammatory response after
EVAR have not been extensively examined in the litera-
ture. Some authors suggest taking careful consideration
of the postoperative administration of steroids to reduce
the biologic responses, whereas others recommend the
aggressive use of drugs in the acute phase when patients
show expressive clinical signs of inﬂammation.7,8 Gerasi-
midis et al10 reported the development of systemic inﬂam-
matory response syndrome in 10% of patients despite the
administration of both NSAIDs perioperatively and
steroids consisting of 500 mg of hydrocortisone intraoper-
atively. The routine administration of drugs such as
steroids or NSAIDs is of concern because of their side
effects, especially in patients with several comorbidities,
including renal and heart failure or coronary artery
disease. However, in some cases, when high-risk patients
present with severe inﬂammatory response after EVAR,
the postoperative administration of anti-inﬂammatory
drugs could be beneﬁcial in preventing consequent serious
morbidity. These issues must be clariﬁed in specially
designed studies.
CONCLUSIONS
Endograft type appears to inﬂuence the inﬂammatory
response after EVAR. The PIS was apparent during the ﬁrst
24 hours postoperatively and decreased afterward. The
Anaconda and Zenith endografts induce a more intense
inﬂammatory response. A “milder” inﬂammatory activation
was observed in patients with the Excluder endograft. PISwas not associated with perioperative adverse clinical events
showing a benign course. The possible long-term sequelae
of PIS require further investigation.
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